Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The closing price of Nurix Therapeutics Inc (NASDAQ: NRIX) was $19.60 for the day, up 2.40% from the previous closing price of $19.14. In other words, the price has increased by $2.40 from its previous closing price. On the day, 0.58 million shares were traded. NRIX stock price reached its highest trading level at $20.15 during the session, while it also had its lowest trading level at $19.32.
Ratios:
Our analysis of NRIX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 5.28 and its Current Ratio is at 5.28. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 10, 2024, initiated with a Buy rating and assigned the stock a target price of $35.
On December 06, 2024, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $35.
On October 24, 2024, UBS started tracking the stock assigning a Buy rating and target price of $35.UBS initiated its Buy rating on October 24, 2024, with a $35 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 02 ’25 when Ring Christine sold 5,760 shares for $19.50 per share. The transaction valued at 112,295 led to the insider holds 28,084 shares of the business.
CHRISTINE RING bought 5,760 shares of NRIX for $108,518 on Jan 02 ’25. On Dec 02 ’24, another insider, Ring Christine, who serves as the Chief Legal Officer of the company, sold 5,760 shares for $21.73 each. As a result, the insider received 125,155 and left with 28,084 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NRIX now has a Market Capitalization of 1388391552 and an Enterprise Value of 967482112. For the stock, the TTM Price-to-Sale (P/S) ratio is 24.61 while its Price-to-Book (P/B) ratio in mrq is 3.49. Its current Enterprise Value per Revenue stands at 17.147 whereas that against EBITDA is -5.19.
Stock Price History:
Over the past 52 weeks, NRIX has reached a high of $29.56, while it has fallen to a 52-week low of $7.65. The 50-Day Moving Average of the stock is -8.50%, while the 200-Day Moving Average is calculated to be -4.04%.
Shares Statistics:
NRIX traded an average of 893.26K shares per day over the past three months and 744810 shares per day over the past ten days. A total of 70.84M shares are outstanding, with a floating share count of 68.89M. Insiders hold about 2.74% of the company’s shares, while institutions hold 95.12% stake in the company. Shares short for NRIX as of 1735603200 were 10793866 with a Short Ratio of 12.08, compared to 1732838400 on 9346993. Therefore, it implies a Short% of Shares Outstanding of 10793866 and a Short% of Float of 16.350001.
